Showing 191-200 of 2704 results for "".
The Advisor Advantage: Does Your Advisor Bring These Benefits to Your Portfolio?
https://modernaesthetics.com/ma-issues-index/2022-jan-feb/the-advisor-advantage-does-your-advisor-bring-these-benefits-to-your-portfolio/35136/When it comes to financial planning, choosing the right advisor can make a significant impact.MATV News: Revance Wins FDA Nod For Redensity Filler; Obagi Introduces Skintrinsiq, Aesthetic Physicians Cope with Covid-19
https://modernaesthetics.com/series/matv-news/matv-news-revance-wins-fda-nod-for-redensity-filler-obagi-introduces-skintrinsiq-aesthetic-physicians-cope-with-covid-19/33656/FDA Approves Revance’s RHA Redensity filler for perioral rhytids, Obagi enters the device market with introduction of Skintrinsiq, and aesthetic physicians discuss how they’re coping with the recent COVID-19 surge.MATV News: Sculptra Wins Expanded Label; Cutera Introduces truSculpt flex+, AACS Opens Annual Meeting Registration
https://modernaesthetics.com/series/matv-news/matv-news-sculptra-wins-expanded-label-cutera-introduces-trusculpt-flex-aacs-opens-annual-meeting-registration/33653/Galderma’s Sculptra gets an expanded label, Cutera rolls out its next generation muscle-sculpting device—truSculpt flex+, and the American Academy of Cosmetic Surgery opens registration for its annual meeting.MATV News: Thriving in Diversity; Gryphon Acquisition of Revision; Sun Hero Campaign
https://modernaesthetics.com/series/matv-news/matv-news-thriving-in-diversity-gryphon-acquisition-of-revision-sun-hero-campaign/33651/The Thriving in Aesthetics educational series is back for a second season—Thriving in Diversity. Steve Dayan, MD and Sabrina Fabi, MD preview upcoming episodes. Revision Skincare CEO Maria Carell talks about the company’s next steps after its acquisition by Gryphon, and Amy Brodsky, MD wants you toUp Your ‘App’titude
https://modernaesthetics.com/ma-issues-index/2021-sept-oct/up-your-apptitude/35088/Expert share tips on the best apps for your practice.Are Millennials the Next Frontier of Medical Aesthetics?
https://modernaesthetics.com/ma-issues-index/2021-sept-oct/are-millennials-the-next-frontier-of-medical-aesthetics/35082/The downsides of alienating Boomers to cater to Millennials.The Art of the Eyes
https://modernaesthetics.com/ma-issues-index/2021-sept-oct/the-art-of-the-eyes/35081/One busy practice set itself apart by creating a results-driven, combination eye treatment package that yielded better patient results and high patient satisfaction compared to typical non-surgical eye treatment options.Optimizing Chemical Peels in Aesthetic Practice
https://modernaesthetics.com/ma-issues-index/2021-sept-oct/optimizing-chemical-peels-in-aesthetic-practice/35080/With an established history of safety and efficacy, chemical peels are a versatile aesthetic tool with room for growth.An Appeal for Peels
https://modernaesthetics.com/ma-issues-index/2021-sept-oct/an-appeal-for-peels/35079/Easy to implement, effective, and cost-effective, peels can have a place in most aesthetic practices.MATV News: Sciton’s BBlink Glasses; Crown to Acquire StriVectin; COVID Impact on Aesthetic Meetings: Galderma Planks for Pink
https://modernaesthetics.com/series/matv-news/matv-news-scitons-bblink-glasses-crown-to-acquire-strivectin-covid-impact-on-aesthetic-meetings-galderma-planks-for-pink/33645/Sciton has introduced new smart goggles designed for provider comfort, Crown Laboratories is set to expand its skincare offerings through acquisition of StriVectin, aesthetic physicians and associations work to make meetings safe amid COVID concerns, and Galderma partners with the National Breast Ca